Research Article
GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism
Table 6
Comparison of TAC C/D ratio among the 4 groups.
| | Posttransplant time | TAC C/D ratio (ng/ml)/(mg/kg/d) | | SS/NEX group () | SS/EX group () | LS/NEX group () | LS/EX group () |
| | 3 days | 113.7 (99.2-150.0) | 62.5 (43.4-100.3) | 74.4 (59.9-100.0) | 51.5 (43.2-82.2) | | 7 days | 104.9 (70.2-192.0) | 75.3 (40.7-117.4) | 70.4 (57.2-102.4) | 41.1 (31.1-76.8) | | 14 days | 69.1 (51.8-132.4) | 31.6 (24.8-59.1) | 42.4 (33.6-58.0) | 28.1 (20.3-46.4) | | 1 month | 59.7 (33.8-89.2) | 31.7 (18.9-49.0) | 34.9 (25.6-50.8) | 20.5 (16.2-28.7) | | 3 months | 71.1 (53.4-91.8) | 30.3 (20.6-47.5) | 53.8 (42.5-68.7) | 27.3 (21.9-37.1) | | 6 months | 75.6 (60.8-103.7) | 34.0 (27.4-47.8) | 69.0 (46.0-95.1) | 41.3 (29.2-47.3) | | 12 months | 80.0 (57.3-92.8) | 42.0 (29.6-63.5) | 79.1 (56.0-136.0) | 49.5 (41.0-85.7) |
|
|
Note: Data are expressed as median (lower quartile-upper qurtile). indicates compared with the SS/NEX group; indicates compared with the SS/NEX group. |
